Clin2
NCT07723352Possibly a fitEnrolling by invitation

Testing Journavx for Thumb Arthritis Surgery Pain

Thumb Basal Joint OsteoarthritisPostoperative PainJoint Replacement SurgeryJoint Replacement

Treatments studied

Part of Pain clinical trials.

This trial tests a new pain medicine called Journavx (suzetrigine) for people having thumb arthritis surgery. It aims to see how well the medicine controls pain after the operation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
40 years to 80 years
Study type
Observational

Who can take part

  • You are between 40 and 80 years old.
  • You are having thumb basal joint surgery (surgery for arthritis at the base of your thumb).
  • You do not have a history of substance abuse or long-term opioid use.
  • You do not have severe kidney or liver disease, and have not had a kidney transplant.
  • You are not currently taking any prescription pain medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07829718Not yet recruiting· Phase 4
Testing a new pain medicine after lower back fusion surgery

This study tests a non-opioid pain medicine called suzetrigine (also known as Journavx) to see how well it controls pain after lower back surgery. It might be a good option if you're having lumbar fusion surgery and want to avoid the side effects of opioid painkillers.

NCT07795827Not yet recruiting· Phase 4
Suzetrigine for pain after ankle replacement

This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.

NCT07864896Recruiting· Phase 3
Study of a new pain medicine after knee replacement surgery

This trial tests a new oral pain medicine called suzetrigine for people who have a knee replacement. It aims to see if it helps control pain after surgery better or with fewer side effects than usual care.

New York, New York
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07866638Not yet recruiting· Phase 4
Suzetrigine for pain after rotator cuff repair

This study tests whether suzetrigine, a new non-opioid pain medicine, can control pain after rotator cuff surgery better than usual care. It may help reduce the need for opioids after surgery.

Hear when a new Postoperative Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.